Wednesday, February 19, 2014 10:44:03 PM
Have you heard about large players (ELAN), FDA, National Cancer Institute fighting over decade to diminish and hide success of Dr. Burzynski antineoplastones to fight most difficult cases of brain cancer? They even tried to steal his patents and one of his crew doctors defected to ELAN, revealing Burzynski's intellectual property and making his road through hell to treat very sick patients.
The history might be repeating. I smell a trouble if there is a more powerful evil behind NNVC attack, not just a short seller looking for a quick profit.
I am worried that big pharma might have started a serious attack on NNVC ( I wish I was wrong). Its a very smart way NNVC made 3 layers of protection to their intellectual property. They should hold tightly on to it so nobody can steal it. Its also a clever move they are busy with their technology studies in Europe, China, Australia and Japan and involve famous scientists like Dr. Harris.
I hope Dr Seymour and other insiders know Dr Burzynski's story, to be a good lesson how to protect rights to their discoveries and how to protect themselves from the evil bureaucrats and jealous competitors.
I advise anyone to check out films below, which are very educational and a must watch to know and prevent.
insert-text-here
insert-text-here
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM